{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T12:29:07Z","timestamp":1787056147922,"version":"build-2736575974"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003996","name":"Kunming Medical University","doi-asserted-by":"publisher","award":["2025B031"],"award-info":[{"award-number":["2025B031"]}],"id":[{"id":"10.13039\/501100003996","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.cellsig.2026.112745","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T14:57:26Z","timestamp":1784645846000},"page":"112745","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["IER5L promotes p53 degradation via TRAF7-mediated ubiquitination to facilitate EMT and colorectal cancer malignancy"],"prefix":"10.1016","volume":"147","author":[{"family":"Guoyu-Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Xudong-Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Qing-Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Enshan-Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Lixing-Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Rong-Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Xuan-Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Xiaoqiong-Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Yunfeng-Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cellsig.2026.112745_bb0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112745_bb0010","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/gutjnl-2015-310912","article-title":"Global patterns and trends in colorectal cancer incidence and mortality","volume":"66","author":"Arnold","year":"2017","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.cellsig.2026.112745_bb0015","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/jama.2021.0106","article-title":"Diagnosis and treatment of metastatic colorectal cancer: a review","volume":"325","author":"Biller","year":"2021","journal-title":"Jama"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112745_bb0020","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2020-000685","article-title":"Towards the era of precision medicine in metastatic colorectal cancer","volume":"5","author":"Napolitano","year":"2020","journal-title":"ESMO Open"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112745_bb0025","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrc.2016.126","article-title":"Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer","volume":"17","author":"Dienstmann","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112745_bb0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41571-019-0241-1","article-title":"Biomarker-guided therapy for colorectal cancer: strength in complexity","volume":"17","author":"Sveen","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112745_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.70164","article-title":"Characterization of LINC00483 as a novel oncogene in colorectal cancer via targeting miR-601\/TSPAN8 signaling axis","volume":"39","author":"Liu","year":"2025","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.cellsig.2026.112745_bb0040","article-title":"PF-04449913 inhibits proliferation and metastasis of colorectal cancer cells by down-regulating MMP9 expression through the ERK\/p65 pathway","volume":"17","author":"Ruan","year":"2024","journal-title":"Curr. Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112745_bb0045","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12943-022-01638-1","article-title":"Hypoxia-induced lncRNA STEAP3-AS1 activates Wnt\/\u03b2-catenin signaling to promote colorectal cancer progression by preventing m(6)A-mediated degradation of STEAP3 mRNA","volume":"21","author":"Zhou","year":"2022","journal-title":"Mol. Cancer"},{"issue":"11","key":"10.1016\/j.cellsig.2026.112745_bb0050","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.70053","article-title":"KDM1A facilitates oncogenic potential in colorectal cancer progression through the activation of AXIN\/GSK3\u03b2\/\u03b2-catenin Signaling pathways: evidence from integrated transcriptomics and in vitro studies","volume":"27","author":"Natarajan","year":"2025","journal-title":"J. Gene Med."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112745_bb0055","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/febs.16612","article-title":"PP2A-B55 and its adapter proteins IER2 and IER5 regulate the activity of RB family proteins and the expression of cell cycle-related genes","volume":"290","author":"Doi","year":"2023","journal-title":"FEBS J."},{"key":"10.1016\/j.cellsig.2026.112745_bb0060","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cellsig.2018.12.012","article-title":"IER family proteins are regulators of protein phosphatase PP2A and modulate the phosphorylation status of CDC25A","volume":"55","author":"Ueda","year":"2019","journal-title":"Cell. Signal."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112745_bb0065","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/s41419-024-06907-z","article-title":"The PP2A regulator IER5L supports prostate cancer progression","volume":"15","author":"Crespo","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellsig.2026.112745_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2024.155270","article-title":"Predictive value of immediate early response 5 like (IER5L) in the prognosis and immune checkpoint blockade therapy of non-small cell lung cancer patients","volume":"256","author":"Wang","year":"2024","journal-title":"Pathol. Res. Pract."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112745_bb0075","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1038\/s41467-022-30382-9","article-title":"p53 wild-type colorectal cancer cells that express a fetal gene signature are associated with metastasis and poor prognosis","volume":"13","author":"Sol\u00e9","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellsig.2026.112745_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.104018","article-title":"The prognostic role of p53 mutations in metastatic colorectal cancer: a systematic review and meta-analysis","volume":"186","author":"Ottaiano","year":"2023","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112745_bb0085","first-page":"77","article-title":"CCT8 drives colorectal cancer progression via the RPL4-MDM2-p53 axis and immune modulation","volume":"18","author":"Teng","year":"2025","journal-title":"BMC Med. Genet."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112745_bb0090","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41419-021-03888-1","article-title":"PRDX2 promotes the proliferation of colorectal cancer cells by increasing the ubiquitinated degradation of p53","volume":"12","author":"Wang","year":"2021","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112745_bb0095","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112745_bb0100","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41392-024-01953-7","article-title":"Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy","volume":"9","author":"Li","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cellsig.2026.112745_bb0105","doi-asserted-by":"crossref","first-page":"19174","DOI":"10.1038\/srep19174","article-title":"IER5 generates a novel hypo-phosphorylated active form of HSF1 and contributes to tumorigenesis","volume":"6","author":"Asano","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellsig.2026.112745_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.960954","article-title":"Multi-omics analysis of the tumor microenvironment in liver metastasis of colorectal cancer identified FJX1 as a novel biomarker","volume":"13","author":"Zou","year":"2022","journal-title":"Front. Genet."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112745_bb0115","article-title":"Construction of a novel radioresistance-related signature for prediction of prognosis, immune microenvironment and anti-tumour drug sensitivity in non-small cell lung cancer","volume":"57","author":"Chen","year":"2025","journal-title":"Ann. Med."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112745_bb0120","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/ncb1086","article-title":"A physical and functional map of the human TNF-alpha\/NF-kappa B signal transduction pathway","volume":"6","author":"Bouwmeester","year":"2004","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112745_bb0125","article-title":"TRAF7 in signaling and disease: emerging mechanisms and clinical implications","volume":"32","author":"Orock","year":"2025","journal-title":"Mol. Med. (Cambridge, Mass.)"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112745_bb0130","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3892\/or.2012.2121","article-title":"Downregulation of ubiquitin E3 ligase TNF receptor-associated factor 7 leads to stabilization of p53 in breast cancer","volume":"29","author":"Wang","year":"2013","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112745_bb0135","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/s41420-021-00749-w","article-title":"TRAF7 contributes to tumor progression by promoting ubiquitin-proteasome mediated degradation of P53 in hepatocellular carcinoma","volume":"7","author":"Zhang","year":"2021","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112745_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/biom14060649","article-title":"Recent advances on mutant p53: unveiling novel oncogenic roles, degradation pathways, and therapeutic interventions","volume":"14","author":"Cordani","year":"2024","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.cellsig.2026.112745_bb0145","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/s41418-025-01463-1","article-title":"Tripartite motif-containing protein 26 promotes colorectal cancer growth by inactivating p53","volume":"32","author":"Tan","year":"2025","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112745_bb0150","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1158\/0008-5472.CAN-12-0759","article-title":"Vaccination with antigen-transfected, NKT cell ligand-loaded, human cells elicits robust in situ immune responses by dendritic cells","volume":"73","author":"Shimizu","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2026.112745_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2026.1745654","article-title":"E3 ubiquitin ligases: structural diversity, dysregulation in disease, and their emerging role in targeted therapeutic strategies","volume":"13","author":"Sriram","year":"2026","journal-title":"Front. Mol. Biosci."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112745_bb0160","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.chembiol.2021.04.008","article-title":"Ubiquitin ligases in cancer: functions and clinical potentials","volume":"28","author":"Duan","year":"2021","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.cellsig.2026.112745_bb0165","article-title":"Spectrum of mesenchymal-epithelial transition aberrations and potential clinical implications: insights from integrative pancancer analysis","volume":"10","author":"Li","year":"2020","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112745_bb0170","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s41420-025-02593-8","article-title":"Epithelial-mesenchymal transition in colorectal cancer metastasis and progression: molecular mechanisms and therapeutic strategies","volume":"11","author":"Nie","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellsig.2026.112745_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109630","article-title":"Syndecan-2 in colorectal cancer plays oncogenic role via epithelial-mesenchymal transition and MAPK pathway","volume":"121","author":"Hua","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cellsig.2026.112745_bb0180","doi-asserted-by":"crossref","DOI":"10.2174\/0115680096383861251003074135","article-title":"Timosaponin AIII inhibits migration and invasion abilities in colorectal cancer through inactivation of PI3K-AKT-mTOR pathway","author":"Xu","year":"2025","journal-title":"Curr. Cancer Drug Targets"},{"issue":"5","key":"10.1016\/j.cellsig.2026.112745_bb0185","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1084\/jem.20110235","article-title":"p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2","volume":"208","author":"Kim","year":"2011","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112745_bb0190","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1158\/1541-7786.MCR-18-0238","article-title":"p53-Pirh2 complex promotes twist1 degradation and inhibits EMT","volume":"17","author":"Yang-Hartwich","year":"2019","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.cellsig.2026.112745_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101848","article-title":"Loss of p53 epigenetically modulates epithelial to mesenchymal transition in colorectal cancer","volume":"43","author":"Sharma","year":"2024","journal-title":"Transl. Oncol."},{"issue":"1\u20132","key":"10.1016\/j.cellsig.2026.112745_bb0200","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1101\/gad.353408.125","article-title":"Mutant p53: evolving perspectives","volume":"40","author":"Efe","year":"2026","journal-title":"Genes Dev."},{"key":"10.1016\/j.cellsig.2026.112745_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113524","article-title":"Ferroptosis in colorectal cancer: potential mechanisms and effective therapeutic targets","volume":"153","author":"Wang","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cellsig.2026.112745_bb0210","doi-asserted-by":"crossref","first-page":"1676414","DOI":"10.3389\/fonc.2025.1676414","article-title":"PROTAC: a revolutionary technology propelling small molecule drugs into the next golden age","volume":"15","author":"Cai","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cellsig.2026.112745_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2025.103055","article-title":"Illuminating ubiquitination mechanisms: how cryo-EM has shed light on Cullin RING E3 ligase function","volume":"92","author":"Rizvi","year":"2025","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112745_bb0220","doi-asserted-by":"crossref","DOI":"10.1186\/s12957-025-04117-1","article-title":"Consensus molecular subtypes (CMS) classification: a progress towards subtype-driven treatments in colorectal cancer","volume":"24","author":"Kantha","year":"2025","journal-title":"World J. Surg. Oncol."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112745_bb0225","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1158\/1078-0432.CCR-23-3964","article-title":"Clinical challenges of consensus molecular subtype CMS4 Colon Cancer in the era of precision medicine","volume":"30","author":"Mouillet-Richard","year":"2024","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112745_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/biology15100759","article-title":"Disrupting the undruggable: emerging modalities for targeting protein-protein interactions in oncology","volume":"15","author":"El-Tanani","year":"2026","journal-title":"Biology"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112745_bb0235","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13045-022-01314-3","article-title":"Targeting p53-MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials","volume":"15","author":"Zhu","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112745_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/life15081280","article-title":"Review of the role of TRAF7 in brain endothelial integrity and cerebrovascular aging","volume":"15","author":"Ihuoma","year":"2025","journal-title":"Life"},{"key":"10.1016\/j.cellsig.2026.112745_bb0245","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.2147\/IJGM.S439190","article-title":"IER5L is a prognostic biomarker in pan-cancer analysis and correlates with immune infiltration and immune molecules in non-small cell lung cancer","volume":"16","author":"Chen","year":"2023","journal-title":"Int. J. Gen. Med."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112745_bb0250","article-title":"Unraveling the role of TP53 in colorectal cancer therapy: from wild-type regulation to mutant","volume":"29","author":"Li","year":"2024","journal-title":"Front. Biosci. (Landmark edition)"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112745_bb0255","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41392-023-01347-1","article-title":"Targeting p53 pathways: mechanisms, structures, and advances in therapy","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Target. Ther."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089865682600402X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089865682600402X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T11:42:36Z","timestamp":1787053356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089865682600402X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":51,"alternative-id":["S089865682600402X"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112745","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IER5L promotes p53 degradation via TRAF7-mediated ubiquitination to facilitate EMT and colorectal cancer malignancy","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112745","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112745"}}